Revolution Medicines Inc (RVMD) — Working Capital to Net Assets Ratio
Revolution Medicines Inc (RVMD) has a Working Capital to Net Assets ratio of 141.0% as of June 2026. Working capital of $3.67 Billion (current assets of $4.03 Billion minus current liabilities of $354.06 Million) is measured against net assets of $2.61 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Revolution Medicines Inc defensive interval ratio to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Revolution Medicines Inc Working Capital to Net Assets (2017–2025)
This chart shows how Revolution Medicines Inc's Working Capital to Net Assets ratio has evolved across 9 annual periods from 2017 to 2025. As of June 2026, the ratio stands at 141.0%, reflecting working capital of $3.67 Billion against net assets of $2.61 Billion USD. For the complete balance sheet picture, see RVMD current and non-current assets.
Annual Working Capital to Net Assets for Revolution Medicines Inc (2017–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Revolution Medicines Inc from 2017 to 2025, covering 9 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Check Revolution Medicines Inc (RVMD) liquid assets ratio to evaluate the company's liquid asset resilience ratio.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 109.4% | $1.78 Billion | $1.63 Billion | $2.08 Billion | $290.42 Million | ▲ +13.9 pp |
| 2024 | 95.5% | $2.16 Billion | $2.27 Billion | $2.33 Billion | $163.91 Million | ▲ +0.5 pp |
| 2023 | 95.0% | $1.74 Billion | $1.83 Billion | $1.88 Billion | $143.85 Million | ▲ +7.7 pp |
| 2022 | 87.3% | $598.20 Million | $685.19 Million | $660.18 Million | $61.98 Million | ▼ -0.6 pp |
| 2021 | 87.9% | $529.42 Million | $602.57 Million | $589.77 Million | $60.35 Million | ▲ +2.1 pp |
| 2020 | 85.7% | $406.95 Million | $474.68 Million | $454.12 Million | $47.18 Million | ▲ +26.1 pp |
| 2019 | 59.6% | $90.93 Million | $152.53 Million | $133.98 Million | $43.05 Million | ▲ +2.8 pp |
| 2018 | 56.8% | $54.88 Million | $96.66 Million | $85.43 Million | $30.55 Million | ▲ +16.1 pp |
| 2017 | 40.7% | $1.84 Million | $4.53 Million | $9.44 Million | $7.60 Million | — |